You are here

Asana Biosciences

Member Since 2018

Sandeep Gupta, PhD

Founder, President and Chief Executive Officer

Asana BioSciences is led by Dr. Sandeep Gupta, who was previously the Senior Vice-President of Discovery and Early Development, Endo Pharmaceuticals. Prior to Endo, Dr. Gupta spent a decade at Forest Laboratories as Head of Drug Discovery and Pharmacology. He played a key role in the development of several block buster drugs during his tenure at Endo and Forest. Before Forest Laboratories, Dr. Gupta held academic positions at the University of Pennsylvania and Boston University Schools of Medicine. Regarded as an architect of the Virtual Drug Discovery Research model, he has pioneered several successful Discovery and Development collaborations across the globe. He is a co-inventor on multiple patents and has authored over 50 scientific papers, presentations and book chapters.

Life Sciences Consortium

LSC  Task Force Participation

Task Force Member(s): Louis Denis MD, Chief Medical Officer

Asana Biosciences

Asana BioSciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel targeted investigational medicines in Oncology, Inflammation/Immunology and Dermatology.

​Asana’s proprietary portfolio consists of multiple small molecule and biological drug candidates. Our oncology clinical development programs are currently evaluating NCEs in patients with hematologic malignancies and solid tumors (e.g., melanoma, colon, and lung). Our dermatology programs include investigational therapies for atopic dermatitis, psoriasis and other skin diseases.

​Asana BioSciences, located near Princeton, NJ, is an independent member of AE Companies.